Magnus Andersson

3.8k total citations
65 papers, 3.0k citations indexed

About

Magnus Andersson is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Magnus Andersson has authored 65 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pathology and Forensic Medicine, 16 papers in Molecular Biology and 15 papers in Immunology. Recurrent topics in Magnus Andersson's work include Multiple Sclerosis Research Studies (21 papers), Peripheral Neuropathies and Disorders (10 papers) and Immunotherapy and Immune Responses (10 papers). Magnus Andersson is often cited by papers focused on Multiple Sclerosis Research Studies (21 papers), Peripheral Neuropathies and Disorders (10 papers) and Immunotherapy and Immune Responses (10 papers). Magnus Andersson collaborates with scholars based in Sweden, United States and Germany. Magnus Andersson's co-authors include Tomas Olsson, Mohsen Khademi, Jan Hillert, Lou Brundin, Lena von Koch, Jon Lampa, Diana Kadetoff, Eva Kosek, Marie Westman and Fredrik Piehl and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Magnus Andersson

64 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magnus Andersson Sweden 32 1.3k 641 583 508 492 65 3.0k
Ilaria Casetta Italy 38 1.1k 0.8× 428 0.7× 483 0.8× 1.2k 2.4× 331 0.7× 149 3.8k
Marcus Koch Canada 36 2.2k 1.7× 444 0.7× 668 1.1× 891 1.8× 520 1.1× 117 4.1k
Jennifer Graves United States 31 1.8k 1.4× 403 0.6× 970 1.7× 714 1.4× 374 0.8× 119 3.4k
Tobias Ruck Germany 34 1.1k 0.9× 819 1.3× 833 1.4× 1000 2.0× 340 0.7× 184 4.0k
Vasilios Kostulas Sweden 28 702 0.5× 1.2k 1.8× 527 0.9× 532 1.0× 193 0.4× 49 2.9k
Raymond Hupperts Netherlands 40 3.1k 2.4× 1.9k 2.9× 635 1.1× 623 1.2× 447 0.9× 124 4.9k
Frederick Munschauer United States 31 3.3k 2.5× 244 0.4× 371 0.6× 1.0k 2.0× 577 1.2× 59 4.4k
Stefan Bittner Germany 39 1.7k 1.3× 1.0k 1.6× 1.5k 2.6× 797 1.6× 305 0.6× 201 4.9k
Joost Smolders Netherlands 33 2.5k 1.9× 1.9k 2.9× 505 0.9× 300 0.6× 263 0.5× 103 4.1k
Zhengqi Lu China 34 1.2k 0.9× 1.1k 1.7× 1.1k 1.9× 1.2k 2.4× 409 0.8× 189 4.5k

Countries citing papers authored by Magnus Andersson

Since Specialization
Citations

This map shows the geographic impact of Magnus Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magnus Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magnus Andersson more than expected).

Fields of papers citing papers by Magnus Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magnus Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magnus Andersson. The network helps show where Magnus Andersson may publish in the future.

Co-authorship network of co-authors of Magnus Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of Magnus Andersson. A scholar is included among the top collaborators of Magnus Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magnus Andersson. Magnus Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fletcher‐Sandersjöö, Alexander, Victor Gabriel El-Hajj, Magnus Andersson, et al.. (2024). Long-term outcome and predictors of neurological recovery in cervical spinal cord injury: a population-based cohort study. Scientific Reports. 14(1). 20945–20945. 4 indexed citations
2.
El-Hajj, Victor Gabriel, Alexander Fletcher‐Sandersjöö, Pascal Jabbour, et al.. (2024). Spontaneous spinal cord infarction: a systematic review. BMJ Neurology Open. 6(1). e000754–e000754. 3 indexed citations
3.
Fletcher‐Sandersjöö, Alexander, Victor Gabriel El-Hajj, Claes Hultling, et al.. (2023). Long-term Outcomes After Periprocedural and Spontaneous Spinal Cord Infarctions. Neurology. 101(2). e114–e124. 6 indexed citations
4.
Piehl, Fredrik, et al.. (2022). Demyelinating events following anti‐tumor necrosis factor alpha therapy: Rare but challenging to treat. European Journal of Neurology. 29(7). 2047–2055. 5 indexed citations
5.
Sveinsson, Ólafur, et al.. (2021). [Spinal cord infarction - a rare condition and a diagnostic challenge].. Läkartidningen. 118. 20131.
6.
Lengqvist, Johan, Elena Ossipova, Helena Idborg, et al.. (2019). Mass spectrometry-based analysis of cerebrospinal fluid from arthritis patients—immune-related candidate proteins affected by TNF blocking treatment. Arthritis Research & Therapy. 21(1). 60–60. 14 indexed citations
7.
Nyberg, William A., Maria Sjöstrand, Noah Moruzzi, et al.. (2018). miR‐31 regulates energy metabolism and is suppressed in T cells from patients with Sjögren's syndrome. European Journal of Immunology. 49(2). 313–322. 13 indexed citations
8.
Bergström, Aileen, Lena von Koch, Magnus Andersson, Kerstin Tham, & Gunilla Eriksson. (2015). Participation in everyday life and life satisfaction in persons with stroke and their caregivers 3–6 months after onset. Journal of Rehabilitation Medicine. 47(6). 508–515. 50 indexed citations
9.
Khademi, Mohsen, Ann Dring, Jonathan D. Gilthorpe, et al.. (2013). Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers. PLoS ONE. 8(5). e63172–e63172. 65 indexed citations
10.
Llano‐Diez, Monica, Guillaume Renaud, Magnus Andersson, et al.. (2012). Mechanisms underlying ICU muscle wasting and effects of passive mechanical loading. Critical Care. 16(5). R209–R209. 94 indexed citations
11.
Jongen, Peter Joseph, Dirk Lehnick, E. A. C. M. Sanders, et al.. (2010). Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study. Health and Quality of Life Outcomes. 8(1). 133–133. 41 indexed citations
12.
Picelli, Simone, Paweł Zając, Xiaolei Zhou, et al.. (2010). Common variants in human CRC genes as low-risk alleles. European Journal of Cancer. 46(6). 1041–1048. 52 indexed citations
13.
Andersson, Magnus, Erik Furusjö, & Andreas Jansson. (2004). Production optimisation in the petrochemical industry by hierarchical multivariate modelling. KTH Publication Database DiVA (KTH Royal Institute of Technology). 1 indexed citations
14.
Schubart, Anna, Sherry Ogg, Magnus Andersson, et al.. (2004). Antibody Cross-Reactivity between Myelin Oligodendrocyte Glycoprotein and the Milk Protein Butyrophilin in Multiple Sclerosis. The Journal of Immunology. 172(1). 661–668. 97 indexed citations
15.
Danilov, Alexandre I., et al.. (2003). Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis. Journal of Neuroimmunology. 136(1-2). 112–118. 89 indexed citations
16.
Andersson, Magnus, Meng Yu, M. Söderström, et al.. (2002). Multiple MAG peptides are recognized by circulating T and B lymphocytes in polyneuropathy and multiple sclerosis. European Journal of Neurology. 9(3). 243–251. 30 indexed citations
17.
Brundin, Lou, Edward Morcos, Tomas Olsson, Peter Wiklund, & Magnus Andersson. (1999). Increased intrathecal nitric oxide formation in multiple sclerosis; cerebrospinal fluid nitrite as activity marker. European Journal of Neurology. 6(5). 585–590. 62 indexed citations
18.
Fiten, Pierre, Koen Vandenbroeck, Bénédicte Dubois, et al.. (1999). Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 and analysis of the association between monocyte chemotactic protein-3 alleles and multiple sclerosis development. Journal of Neuroimmunology. 95(1-2). 195–201. 18 indexed citations
19.
Wallström, Erik, Mohsen Khademi, Magnus Andersson, et al.. (1998). Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+ multiple sclerosis. European Journal of Immunology. 28(10). 3329–3335. 94 indexed citations
20.
Andersson, Magnus, et al.. (1994). Osteoporosis in a largely self-referred population: high prevalence but low medical priority: why?. PubMed. 20(5). 287–93. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ilaria Casetta Breakdown of academic impact, for papers by Marcus Koch Breakdown of academic impact, for papers by Jennifer Graves Breakdown of academic impact, for papers by Tobias Ruck Breakdown of academic impact, for papers by Vasilios Kostulas Breakdown of academic impact, for papers by Raymond Hupperts Breakdown of academic impact, for papers by Frederick Munschauer Breakdown of academic impact, for papers by Stefan Bittner Breakdown of academic impact, for papers by Joost Smolders Breakdown of academic impact, for papers by Zhengqi Lu
Rankless by CCL
2026